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Abstract
Objectives: To evaluate the hypoglycemic and anti-diabetic activity 
of chloroform extract of Calotropis gigantea leaves and flowers in 
normal rats and streptozotocin induced diabetes.
Methods: The hypoglycemic activity in normal rats was carried 
out by treatment using chloroform extract of Calotropis gigantea 
leaf  and  flower  10,  20  and  50  mg/kg,  orally.  The  oral  glucose 
tolerance test was carried out by administering glucose (2 g/kg, 
p.o), to non-diabetic rats treated with leaf and flowers extracts at 
oral doses 10, 20 and 50 mg/kg, p.o and glibenclamide 10 mg/kg. 
The serum glucose was then measured at 0, 1.5, 3 and 5 hr after 
administration of extracts/drug. Streptozotocin-induced diabetic 
rats were administered the same doses of leaf and flower extracts, 
and standard drugs glibenclamide was given to the normal rats or 
0.5 ml of 5% Tween-80, for 27 days. The blood sample from all 
groups collected by retro-orbital puncture on 7, 14, 21 and 27th 
days after administration of the extracts/drug and used for the 
estimation of serum glucose levels using the glucose kit.
Results:  The  Calotropis  gigantea  leaves  and  flowers  extracts 
were  effective  in  lowering  serum  glucose  levels  in  normal  rats. 
Improvement  in  oral  glucose  tolerance  was  also  registered  by 
treatment with Calotropis gigantean. The administration of leaf 
and flower extracts to streptozotocin-induced diabetic rats showed 
a significant reduction in serum glucose levels.
Conclusion: It is concluded that chloroform extracts of Calotropis 
gigantea leaves and flowers have significant anti-diabetic activity.
Keywords: Diabetes; Antidiabetic; Calotropis gigantea; Oral glucose 
tolerance test; OGTT; Hypoglycemic.
Introduction
Diabetes  is  the  world’s  largest  endocrine  disease  with 
deranged carbohydrate, fats and protein metabolism. As part of 
the pathogenesis of type 2 diabetes; skeletal muscle, liver, glucose 
and  adipose  tissue  become  resistant  to  the  hormonal  effect  of 
insulin, which in turn lead to decreased insulin-mediated glucose 
disposal, hepatic glucose overproduction and a marked increase in 
lipolysis.1 There are an estimated 143 million people in the world 
with diabetes mellitus and this number will probably double by the 
year 2030.2 Due to the enormous costs of modern treatment for 
diabetes in developing countries, the use of medicinal plants and 
their preparation has flourished as an alternative for the control 
and prevention of the disease.3 
Currently, there are several drugs available for treatment of 
diabetes mellitus but most of them are synthetic drugs and this 
makes the anti-diabetic treatment costly. In view of reducing the cost 
of treatment for diabetes mellitus, there is considerable research for 
herbal production as anti-diabetics and around 12000 plants have 
been reported to possess anti-diabetic property.4 Swarnabhasma; 
an  Ayurvedic  preparation  containing  Calotropis  gigantea  R.  Br 
(C.  gigantea)  and  flowers  were  extensively  used  by  Ayurvedic 
physicians for treatment of disorders such as diabetes mellitus, 
bronchial asthma, rheumatoid arthritis, and nervous disorders.5,6 
Chloroform extract of C. gigantea leaves and flowers prevent insulin 
induced resistance in high fructose diet.7 Another member of this 
genus, Calotropis procera has also been reported to possess anti-
diabetic activity.8 C. gigantea has been reported to contain proteases, 
3'-methylbutanoates of amyrin,9 flavonol glycosides,10 calotropins,11 
Stigmasterol and sitosterols,12 cardenolides,13 and pregnanone.14
Its  roots  have  been  used  in  leprosy,  eczema,  syphilis, 
elephantiasis, ulceration, anti-diarrhoeal, and cough in the Indian 
system  of  traditional  medicine.15  Antipyretic  and  analgesic 
activities,11,16 of the alcohol extract of peeled roots of C. gigantea 
were also recently reported in mice models.17,18 The milky juice 
of  C.  gigantea  has  been  reported  to  be  a  violent  purgative  and 
gastrointestinal irritant and as being used for inducing abortion.19 
The crude latex extract is reported to exhibit strong proteolytic 
activity, being able to hydrolyse casein, human fibrinogen and crude 
fibrin clot in a dose dependent manner.20 It has also been reported 
for Antiamoebic,21 wound healing,22 hepatoprotective,23 and anti-
oxidant,24 properties.
Oman Medical Journal (2011) Vol. 26, No. 2: 104-108
DOI 10. 5001/omj.2011.26Oman Medical Specialty Board
Recently,  many  natural  products  containing  glycosides, 
flavonoids and steroids are being reported to possess anti-diabetic 
and hypoglycaemic effects due to their anti-inflammatory and anti-
oxidant properties.25-28 Previous studies carried out on C. gigantea 
have  indicated  the  presence  of  proteases,  glycosides,  flavonoids 
and phenolic compounds and were proven to be responsible for 
antioxidant and anti-inflammatory properties.9-14,17 
Based  on  these  findings,  we  hypothesized  that  this  plant 
preparation  may  also  exhibit  hypoglycemic  and  anti-diabetic 
properties.  Therefore,  the  present  study  was  designed  with  an 
objective to evaluate possible anti-diabetic activity of C. gigantea 
using chloroform extract of leaves and flowers in diabetic rats and 
also to determine improvement in glucose tolerance by using oral 
glucose tolerance test (OGTT).
Methods
C.  gigantea  leaves  and  flowers  were  collected  in  the  region  of 
Bagalkot-Karnataka India, during September - October 2005. The 
plant was authenticated at the Dept. of Botany, Basaveswara Science 
College,  Bagalkot-Karnataka  India.  A  voucher  specimen  (BSC/
BOT/04/09) was deposited in the same Institute.
The plant material was shade-dried and uniformly powdered by 
passing through the sieve #44 and then subjected to hot continuous 
extraction with petroleum ether (40-60°C) to defat the preparation, 
followed by chloroform, ethyl acetate and methanol extraction for a 
24 hr cycle. The crude extract solution was concentrated by using 
rotary  flash  evaporator  to  produce  a  semisolid  mass,  and  dried 
in lyophilizer (Mini Lyotrap, Serial No. J8199/5, LET Scientific 
LTD, UK).
The Streptozotocin was purchased from Sigma Chemical Co St 
Louis, USA. Petroleum ether (40-60°C) chloroform, ethyl acetate, 
and methanol AR grade were purchased from Nice Pvt Ltd, India.
The extracts were then formulated as suspension in distilled 
water using 5% Tween-80 as suspending agent.29 When different 
extracts were tested for hypoglycemic activity on normal rats, the 
chloroform  extract  was  the  only  effective  one  and  was  the  one 
selected for further treatment. The dose ranges were selected based 
on previous studies.17 Henceforth, CECGL and CECGF refers to 
chloroform extracts of C. gigantea leaves and flowers respectively.  
Wistar  albino  rats  (150-200  g)  of  either  sex  were  used  in 
this study, after one week period of acclimatization to laboratory 
conditions. The animals were housed under standard environmental 
condition of temperature (21 ± 2°C), humidity (51 ± 10%) and 12 
hr light-dark cycles with standard pellet diet (Amrut Lab) and water 
ad libitum. Animals were divided into various groups, each group 
consisted of three male and three female rats. All the experiments 
were  carried  out  as  per  the  guidelines  of  Institutional Animals 
Ethics Committee (RGE No.821/A/CPCSEA) of College after 
approval (HSK/IAEC.Clear/2004-2005) dated 27/12/04.
Anti-diabetic  activity  of  chloroform  extract  of  leaves  and 
flower was evaluated using STZ- induced diabetic rats. The STZ 
was dissolved in citrate buffer (pH 4.5) and was administered by 
intraperitoneal route at 55 mg/kg for each rat and their serum 
glucose levels were estimated after 72 hr. The rats’ serum glucose 
levels which were over and above 300 mg/dl were considered to be 
diabetic resembling chronic diabetic condition and hence they were 
selected and divided into eight groups of six rats each.1 
To determine the hypoglycemic activity in normal rats, the rats 
were kept on fasting for 18 hrs and were divided into seven groups 
of six rats each.
Group 1: served as the controls, 0.5 ml of 5% Tween-80 in 
distilled water orally. Tween-80 was used as a suspending agent to 
suspend the extract for oral administration. 
Group 2: CECGL extract 10 mg/kg, p.o
Group 3: CECGL extract 20 mg/kg, p.o
Group 4: CECGL extract 50 mg/kg, p.o
Group 5: CECGF extract 10 mg/kg, p.o
Group 6: CECGF extract 20 mg/kg, p.o
Group 7: CECGF extract 50 mg/kg, p.o
The blood samples from all groups were drawn by retro-orbital 
plexus from each rat, under anesthesia at 0, 1.5, 3 and 5 hrs after 
CECGL and CECGF extract administration. The serum glucose 
levels were estimated from all blood samples using a glucose kit.1 
For the oral glucose tolerance test, the rats were kept on fasting 
for 18 hrs and then divided into eight groups of six rats each:
Group  1:  served  as  the  control,  0.5  ml  of  5% Tween-80  in   
distilled water, p.o
Group 2: glibenclamide 10 mg/kg, p.o
Group 3: CECGL extract 10 mg/kg, p.o
Group 4: CECGL extract 20 mg/kg, p.o
Group 5: CECGL extract 50 mg/kg, p.o
Group 6: CECGF extract 10 mg/kg, p.o
Group 7: CECGF extract 20 mg/kg, p.o
Group 8: CECGF extract 50 mg/kg, p.o
The rats of all groups were loaded with glucose (2 g/kg) 30 
minutes after administration of extracts/ drugs. Blood samples were 
withdrawn from each rat at 0, 0.5, 1.5, and 3 hrs after CECGL and 
CECGF extract administration and the serum glucose levels were 
then estimated from all blood samples using a glucose kit [30, 31] 
To determine the anti-diabetic activity, the rats were grouped 
as follows:
Group 1: served as the controls, 0.5 ml of 5% Tween-80 in 
distilled water, p.o
Group 2: glibenclamide 10 mg/kg, p.o
Group 3: CECGL extract 10 mg/kg, p.o
Group 4: CECGL extract 20 mg/kg, p.o
Group 5: CECGL extract 50 mg/kg, p.o
Group 6: CECGF extract 10 mg/kg, p.o
Group 7: CECGF extract 20 mg/kg, p.o
Group 8: CECGF extract 50 mg/kg, p.o
The blood samples from all groups were drawn on the 7, 14, 21, 
and 27th days after administration of CECGL and CECGF  
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extracts and were used for estimation of serum glucose levels using 
a  glucose  kit.30,31  All  data  collected  from  the  experiment  were 
expressed as the mean ± standard error (SEM) and analyzed by 
student  t  test  by  using  Graphpad  prism  4.02-version  software 
(USA). [30, 31] 
Results 
The hypoglycemic effect of CECGL and CECGF extracts oral dose 
10, 20 and 50 mg/kg were found to be effective in lowering serum 
glucose levels in normal rats. 
Table 1: Hypoglycemic effect of chloroform extracts of Calotropis gigantea leaf and flower in normal rats.
Mean blood serum glucose ± SEM (mg/dl) at the intervals
 Treatments   0 hr                        1.5 hrs                                3 hrs   5 hrs
Controla    91.0 ± 3.0      89.2 ± 4.9      101.2 ± 4.5      101.8 ± 6.2
CECGLb 10 mg/kg     85.2 ± 5.9      69.8 ± 5.9*          66.8 ± 6.4* 70.6 ± 4.0*
CECGL b20 mg/kg     82.8 ± 3.9      69.9 ± 6.9*          63.1 ± 4.9*  63.9 ± 4.4*
CECGLb 50 mg/kg     83.1 ± 4.2      56.0 ± 5.4*      51.4 ± 4.3**    57.5 ± 3.9*
CECGFc 10 mg/kg     82.3 ± 5.3      57.1 ± 5.0**    53.8 ± 4.1*      70.6 ± 1.6*
CECGFc 20 mg/kg     78.9 ± 4.5      64.9 ± 4.9*      53.7 ± 3.4**    61.3 ± 2.3*
CECGFc 50 mg/kg     73.4 ± 7.5      48.8 ± 3.2*      39.9 ± 2.2** 8.2 ± 2.0*
 
a(0.5 ml of 5% Tween 80) CECGLb: (Chloroform extract of Calotropis gigantea leaves); CECGFc: (Chloroform extract of Calotropis gigantea flowers). Values are 
expressed in terms of the standard error of the mean (SEM) n=6 in each group *p <0.05, **p <0.01. When student t test (paired) compared 0 hr with the interval 
of 1.5, 3 and 5 hr. 
Table 2: Effect of chloroform extracts of Calotropis gigantea leaf and flower on glucose tolerance in normal rats .
Mean blood serum glucose ± SEM (mg/dl) at the intervals
 Treatments   0 hr                       1.5 hrs                                 3 hrs 
Control (glucose 2 g/kg)  122.7 ± 3.1 78.2 ± 3.4 153.7 ± 4.6 144.1 ± 3.9
Glibena 10 mg/kg + glucose 2 g/kg  78.7 ± 4.0***  75.4 ± 2.1 116.9 ± 5.3*** 94.56 ± 3.1***
CECGLb 10 mg/kg + glucose 2 g/kg  111.2 ± 3.8* 86.5 ± 6.1 132.6 ± 3.2** 126.0 ± 3.5**
CECGLb 20 mg/kg + glucose 2 g/kg  95.2 ± 5.2** 82.9 ± 3.3 127.1 ± 5.7** 117.4 ± 4.7**
CECGLb 50 mg/kg + glucose 2 g/kg  96.5 ± 5.3** 80.0 ± 3.9 125.9 ± 5.4** 116.4 ± 7.1**
CECGFc 10 mg/kg + glucose 2 g/kg  107.0 ± 5.5* 83.6 ± 4.5 132.4 ± 2.5**  126.7 ± 2.2**
CECGFc 20 mg/kg + glucose 2 g/kg  109.1 ± 3.8* 76.9 ± 5.3 131.3 ± 2.7** 124.8 ± 2.2**
CECGFc 50 mg/kg + glucose 2 g/kg  107.5 ± 3.4** 77.2 ± 4.6 129.7 ± 2.7**  122.0 ± 1.9***
aGlibenclamide; CECGLb: (Chloroform extract of Calotropis gigantea leaves); CECGFc: (Chloroform extract of Calotropis gigantea flowers). Values are expressed 
in terms of the standard error of the mean (SEM) n=6 in each group *p <0.05, **p <0.01 ***p <0.001, when student t test (Unpaired) compared to control.  
  
The anti-diabetic effect of CECGL and CECGF extracts for 27 days of treatment were found to be effective even at an oral dose of 10 
mg/kg (p<0.001) in lowering serum glucose levels in STZ-induced diabetic rats. However, the reduction in serum glucose levels was better 
on the 21st and 27th days of treatment. The results further revealed that the maximum serum glucose suppression occurred on the 27th day 
after CECGL and CECGF extracts treatment, when compared to the control. Glibenclamide at 10 mg/kg caused a significant (p<0.001) 
reduction in serum glucose on all days. (Table 3)
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The  CECGF  at  50  mg/kg  exhibited  significant  (p<0.01) 
hypoglycemic  effects  compared  to  leaves  at  3  hrs  intervals.  The 
serum glucose levels were proportionately reduced with increase in 
dose of CECGL and CECGF. It is evident from the results that 
the  CECGF  exhibited  better  hypoglycemic  effects  compared  to 
CEGGL. (Table 1)
For the OGTT, CECGL and CECGF extracts, an oral dose of 
50 mg/kg was found to be effective in lowering serum glucose levels. 
There was a significant (p<0.01) reduction in serum glucose levels 
at time intervals of 0.5-1.5 hr. (Table 2)Oman Medical Specialty Board
Discussion
In order to establish a scientific basis for the utilization CECGL 
and CECGF extracts in the treatment of diabetes, it was decided to 
evaluate the hypoglycemic effect, the OGTT in normal and STZ-
induced  diabetic  rats.  Earlier  reports  reveal  that  STZ-induced 
diabetic animals may exhibit most of the diabetic complications 
mediated  through  oxidative  stress.32  Glibenclamide  is  often 
used as an insulin stimulant in many studies, and also used as a 
standard anti-diabetic drug in STZ-induced moderate diabetes to 
compare the anti-diabetic properties of a variety of hypoglycemic 
compounds.32,33 The findings of our study show that CECGL and 
CECGF have potent anti-diabetic activity in rats. The preliminary 
qualitative  chemical  tests  of  CECGL  and  CECGF  confirmed 
the  presence  of  glycosides,  alkaloids,  flavonoids  and  tannins  by 
methods,34 supporting the earlier studies on C. gigantea.10,29 The 
glycosides may be responsible for observed pharmacological activity.
[33]
Overall, the results show that the CECGL and CECGF possess 
marked hypoglycemic activity that resulted in improvement of oral 
glucose tolerance and lowering of the serum glucose levels in STZ-
induced diabetic rats. The obtained results provide support for the 
use of the plant in traditional medicine. On the basis of the above 
evidence, it may be possible that the presence of flavonol glycosides 
may be responsible for the observed anti-diabetic activity.10,28 
Conclusion
As far as the mechanism of action is concerned, we may speculate 
that the anti-diabetic activity of the extract may increase the glucose 
uptake,33 or may be partly mediated through suppression of the 
gluconeogenic  enzymes,  glucose-6-phosphatase.35  However,  the 
precise mechanism(s) and site(s) of activity and active constituent(s) 
of chloroform extracts of C. gigantea leaves and flowers in addition 
to their toxicological effects have to be determined before concrete 
recommendation for drug development can be made.
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